SANDOZ AFATINIB

Identification of Sandoz Afatinib

No description

Google image searchProduct monograph

Active ingredient

afatinib (afatinib dimaleate), 30 MG

DIN: 02512785

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 28-OCT-2024

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
• L01EB03 — AFATINIB (ATC/DDD)

Reference brand drug: Giotrif

External Links for Sandoz Afatinib

Search on Google

• Sandoz Afatinib side effects
• Sandoz Afatinib dosage
• afatinib side effects
• afatinib dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz afatinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.